Search research articles
Contact Us
Filters
Showing results (421-430 of 483) with videos related to
Page
of 49
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 29, 2024
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
Martin Filipits, Margaretha Rudas, Raimund Jakesz, et al.
Hemasphere
|
April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients
Lukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Journal of Geriatric Oncology
|
June 17, 2026
Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi setting
Paolo Ghia, Davide Rossi, Emmanuelle Ferrant, et al.
The New England Journal of Medicine
|
September 8, 2010
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
Andreas Engert, Annette Plütschow, Hans Theodor Eich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Haematologica
|
July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
Julia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
Lancet (London, England)
|
June 5, 2015
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant, Georg Pfeiler, Peter C Dubsky, et al.
Lancet (London, England)
|
November 5, 2019
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness, Kevin J Harrington, Richard Greil, et al.
Page
of 49
Search research articles
Search
Showing results (421-430 of 483) with videos related to
Sort By:
Page
of 49
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 29, 2024
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
Martin Filipits, Margaretha Rudas, Raimund Jakesz, et al.
Hemasphere
|
April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients
Lukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Journal of Geriatric Oncology
|
June 17, 2026
Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi setting
Paolo Ghia, Davide Rossi, Emmanuelle Ferrant, et al.
The New England Journal of Medicine
|
September 8, 2010
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
Andreas Engert, Annette Plütschow, Hans Theodor Eich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Haematologica
|
July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
Julia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
Lancet (London, England)
|
June 5, 2015
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant, Georg Pfeiler, Peter C Dubsky, et al.
Lancet (London, England)
|
November 5, 2019
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness, Kevin J Harrington, Richard Greil, et al.
Page
of 49